Kinfo
Biote Corp. logo

Biote Corp.

BTMDNASDAQHealthcare·US · USD
$1.50
+0.08 (+5.63%)
Prices as of August 13, 2026 · live

Price

Key statistics

Valuation
Market cap50.49M USD
Enterprise value169.15M USD
Trailing P/E10.50
Forward P/E3.27
PEG ratio-0.12
Price / sales0.28
Price / book-0.96
Profitability
Gross margin68.88%
Operating margin-7.93%
Profit margin3.19%
Return on assets9.33%
Return on equity-53.66%
Income (TTM)
Revenue183.53M USD
Gross profit125.86M USD
EBITDA32.80M USD
Net income5.86M USD
Diluted EPS$0.14
Rev. growth (YoY)-9.50%
Balance sheet
Total cash11.17M USD
Total debt128.64M USD
Debt / equity-2.68
Current ratio1.43
Book value / share-$2.30
Cash flow (TTM)
Operating cash flow24.37M USD
Levered free cash flow-9.51M USD
Shares & price
Shares outstanding29.99M
Float18.49M
Held by institutions62.51%
Beta1.65
50-day MA$2.17
200-day MA$2.21
52-week high$3.62
52-week low$1.27
Dividends
Forward rate
$0.00
Yield
0.00%
Payout ratio
0.00%
Frequency
Unknown
Earnings (EPS)
DateEst.ActualSurprise2026-08-050.030.04+33.33%2026-07-230.270.24−11.11%2026-06-110.170.31+82.35%2026-06-020.230.17−26.09%2026-05-060.080.08+0.00%
About Biote Corp.

Biote Corp. is a healthcare company specializing in hormone optimization and preventive medicine. It operates a comprehensive practice-building platform known as the Biote Method, which equips certified practitioners with education, training, certification, practice management software, inventory management tools, and digital marketing support to deliver bioidentical hormone replacement pellet therapy. This therapy addresses hormonal imbalances in men and women, promoting therapeutic wellness and healthy aging. Biote Corp. also offers Biote-branded dietary supplements and sterile pellet insertion kits essential for hormone optimization treatments. The company supports a network of physicians and nurse practitioners, enabling them to implement personalized hormone therapy programs effectively. Through its end-to-end solutions, Biote Corp. plays a key role in the growing hormone optimization sector within preventive healthcare. Founded in 2012 and headquartered in Irving, Texas, it focuses on empowering providers to optimize patient hormone levels using precise, bioidentical approaches.

Sector
Healthcare
Industry
Medical Care Facilities
CEO
Mr. Robert C. Peterson
Employees
223
Headquarters
Irving, TX, United States

Frequently asked questions about Biote Corp.